Abstract
The serotonin 2 receptor (5HT2R) agonist psilocybin displays rapid and persistent therapeutic efficacy across neuropsychiatric disorders characterized by cognitive inflexibility. However, the impact of psilocybin on patterns of neural activity underlying sustained changes in behavioral flexibility has not been characterized. To test the hypothesis that psilocybin enhances behavioral flexibility by altering activity in cortical neural ensembles, we performed longitudinal single-cell calcium imaging in the retrosplenial cortex across a five-day trace fear learning and extinction assay. A single dose of psilocybin induced ensemble turnover between fear learning and extinction days while oppositely modulating activity in fear- and extinction- active neurons. The acute suppression of fear-active neurons and delayed recruitment of extinction-active neurons were predictive of psilocybin-enhanced fear extinction. A computational model revealed that acute inhibition of fear-active neurons by psilocybin is sufficient to explain its neural and behavioral effects days later. These results align with our hypothesis and introduce a new mechanism involving the suppression of fear-active populations in the retrosplenial cortex.
Introduction.
Neuropsychiatric disorders characterized by inflexible associative learning, such as depression, anxiety, substance use-disorders, and post-traumatic stress disorder, affect over 350 million people worldwide1. Serotonergic psychedelics, including psilocybin, demonstrate remarkable transdiagnostic potential across these disorders2. After only a single dose, many patients report long-lasting improvements in depression and SUDs, as well as overall well-being for up to a year—a time-span implicating the involvement of cortically mediated long-term memory3–6. Therapeutic-like effects also have been observed in rodent models in many behavioral studies7–15, enabling the study of the neural mechanisms of psilocybin-enhanced mental health outcomes in mice.
Psilocybin is a naturally occurring compound found in hundreds of species of mushroom. Upon first pass metabolism, psilocybin is dephosphorylated into its active metabolite psilocin – a potent serotonin receptor agonist16,17. While psilocybin’s subjective effects tend to be accompanied by feelings of extreme “bliss”, “unity”, and “meaningfulness”2,18, in a subset of patients, psilocybin can induce anxiogenic and even traumatic experiences, in some cases associated with long-term psychosis and suicidal ideation19–24. To develop safe therapies with minimal adverse side-effects, it is critical to identify the relevant neural subpopulations differentially modulated by psilocybin to produce long-lasting therapeutic effects.
Clinical researchers found that therapeutic effects of serotonergic psychedelics in humans are mediated by increased cognitive flexibility following drug experience, a finding recapitulated in rodent models25–28. Evidence from human, rodent, and molecular research converges on the hypothesis that psilocybin generates highly plastic brain states conducive to modifying circuits that underlie inflexible, maladaptive behaviors via 5HT2R and TrkB activation2,17,29–36. Acute activation of cortical neurons by psychedelics induces synaptic AMPA receptor insertion, BDNF signaling, and consequent dendritic growth32,35,37,38. It is unknown how these molecular actions of psilocybin impact information processing in neural ensembles associated with aversive memories and maladaptive behavioral patterns.
The retrosplenial cortex (RSC) is one region where psilocybin may alter information processing in a manner sustaining enhanced behavioral flexibility. The RSC implements a variety of abstract functions39, including encoding and retrieval of episodic memory40–51; imagination of the future39; value and context encoding44–48; egocentric navigation and reasoning49,52–54; and ego dissolution under psychedelics55. Chemogenetically inhibiting RSC during reversal learning impairs performance after a rule switch, suggesting RSC activity is crucial for behavioral flexibility48. Replay of neural activation in the RSC is also involved in the production, consolidation, and generalization of fear engrams51. In another study, Wang et al., 2019 identified a previously silent ensemble recruited in RSC during contextual fear extinction, another form of behavioral flexibility56. When the authors optogenetically reactivated this ensemble after re-conditioning, extinction was reinstated, suggesting that excitatory plasticity in the RSC drives fear extinction. The increase in c-FOS-expressing neurons after extinction observed by Wang et al. was recently replicated and shown to be sex-independent56,57.
Several lines of evidence suggests that psilocybin’s effects could in part be mediated by changes in RSC activity. Psilocybin increases c-FOS expression throughout the cortex but idiosyncratically alters neural oscillations specifically in the RSC58,59. While 5HT2ARs are distributed throughout cortical L5 pyramidal neurons, the RSC is the only cortical region that also contains 5HT2CRs on pyramidal neurons60,61. In humans with depression, functional connectivity between the dorsal raphe nuclei and posterior cingulate regions homologous to rodent RSC is impaired62. Subsequent improvements in functional connectivity between the posterior cingulate and prefrontal cortex predict psilocybin-induced enhancements in cognitive flexibility20. Importantly, the RSC is involved in the retrieval of remote fear memories, positioning it as a potential substrate for psilocybin’s longer-lasting effects62–66.
To investigate the role of the RSC in the post-acute effects of psilocybin on behavioral flexibility, extinction of trace fear conditioning (TFC) was employed as the appropriate primary behavioral paradigm. TFC is a model of complex fear learning in rodents, in which a conditioned stimulus (CS) is followed by a trace period of 20-seconds preceding the shock. The trace period in TFC renders conditioning and extinction cortex-dependent, requiring protracted attention to associate temporally distant stimuli68–70. When the shock is omitted during extinction, animals must learn that it is now safe to reduce their freezing response or extinguish. In mice, Kwapis et al. found that TFC extinction depends on excitatory activity in the RSC68. Others have shown that optical, electrolytic, and pharmacological interventions in the RSC impact various kinds and stages of FC45,49,50,55,63–71. In a one-day paradigm, psilocybin administered 24 hours prior facilitated TFC extinction at low doses72. However, this study did not investigate the effect of psilocybin on long-term, consolidated fear memory, which is of translational interest.
To evaluate the hypothesis that psilocybin promotes behavioral flexibility by rapidly and persistently altering RSC ensembles associated with aversive memories, we investigated the effects of a single dose of psilocybin in a multi-day TFC extinction paradigm. We repeated this experiment in GCaMP8m-expressing, miniature microendoscope-implanted mice to measure single-cell calcium activity throughout the task. Using tensor component analysis (TCA)73, we identified ensembles driving RSC activity during different cognitive phases of the task - acquisition, early extinction/fear recall, and late extinction. We confirmed our hypothesis that psilocybin accelerates and enhances the recruitment of an extinction-associated ensemble, particularly in drug-responsive animals. To our surprise, we found that fear extinction was also associated with an acute, robust suppression of fear-associated neurons during psilocybin administration. These effects on neural activity predicted extinction, and a computational model revealed that this inhibition is in fact sufficient to explain enhanced recruitment in extinction-associated neurons as well as behavioral variability. Taken together, these results support two mechanisms of psilocybin-enhanced fear extinction in the RSC, based on opposing forms of plasticity, which act in concert to reduce behavioral inflexibility.
Results.
Psilocybin enhances Trace Fear Extinction (TFC) extinction in a responsive subpopulation of mice.
Mice underwent a five-day TFC paradigm, with one Habituation, one Acquisition, and three Extinction Sessions (Fig. 1a). Freezing was measured in ezTrack74 as percent of time immobile during the trace period. Mice were administered psilocybin (1.0 mg/kg, i.p.) or saline 30 min before Extinction 1. This time-point was chosen as psilocybin-induced head twitches, the behavior taken as a proxy for the subjective effects in animals, peak around 15 min and last for up to 150 min42. Both groups froze significantly more during the first trace period of Extinction 1 than baseline, indicating successful TFC acquisition (Supplementary Fig. 1e, Supplementary Table 1). Psilocybin did not affect recall during Extinction 1, defined as freezing in the first half of the session (Fig 1b, Supplementary Table 1). Nonetheless, psilocybin mice reduced freezing more quickly during Extinction 1, indicating that psilocybin acutely accelerated fear extinction. (Supplementary Fig 1a, Supplementary Table 1) Psilocybin significantly reduced freezing during early Extinction 2, indicating enhanced extinction recall. By Extinction 3 there was no significant difference between groups, nor at a one-month follow-up (Fig. 1b, Supplementary Fig. 1a,f, Supplementary Table 1). Overall, there was no difference between males and females in either condition (Supplementary Fig. 1b,c, Supplementary Table 1).
The extinction rate was calculated as the percent difference between freezing in late Acquisition and late Extinction 3. We chose this definition to circumvent the confounding variable of drug-induced changes in mobility during Extinction 1. Notably, there was a trend towards psilocybin-enhanced extinction rate, with a skewed distribution of extinction rates in psilocybin and saline groups (Fig. 1c, Supplementary Table 1). As extinction rate was one of our primary outcomes, mice that had extinguished >50% of their late Acquisition freezing by late Extinction 3 were classified as rapidly extinguishing and all others as slowly extinguishing.
Intriguingly, psilocybin-administered rapidly extinguishing mice reduced freezing more quickly than all other groups (Fig. 1d, Supplementary Table 1). This effect was greatest during early Extinction 2, suggesting psilocybin particularly enhanced recall of extinction memory. In contrast, freezing in slowly extinguishing mice was unaffected by treatment (Fig. 1d, Supplementary Table 1). There was the same proportion of rapid and slow extinguishing mice in each group (Fig. 1e).
To determine whether there was subpopulation of psilocybin non-responsive mice or whether it is always the case that mice that freeze more during recall extinguish slowly, we asked if freezing during the psilocybin’s acute effects in Extinction 1 would predict extinction class. (Fig. 1f,g left, Supplementary Table 1) Interestingly, the percent freezing during late Extinction 1 predicted classification as either rapidly or slowly extinguishing only if mice were administered psilocybin (auROC = 0.9176, p = 0.0054), but not saline (auROC = 0.6488, p = 0.2225). Indeed, freezing in psilocybin rapid-extinguishers was significantly lower than slow-extinguishers during acute psilocybin administration and consistently throughout the subsequent days. On the other hand, saline rapid- and slow-extinguishers are only differentiated at the timepoints used to define the classes, suggesting there were no pre-existing distinctions between the groups. Thus, we identified two classes of psilocybin-responsive versus non-responsive mice, hereon referred to as “responders” and “non-responders” respectively.
Miniscope-implanted mice acquire and extinguish TFC.
To explore the neurophysiological correlates of psilocybin-enhanced TFC extinction, single cell calcium activity was recorded in the RSC of saline and psilocybin mice. Mice were injected with AAV9-hSyn-GCaMP8m in the RSC and two weeks later implanted with a 1.0 mm diameter, gradient refractive index (GRIN) lens over the injection site (Fig. 2a B). After 2-5 weeks, mice were trained in the same TFC task (Fig. 2c). Calcium traces were extracted using CNMF-E in the Inscopix Data Processing Software API and post-processed (Fig. 2d). Across the entire TFC imaging protocol, 11-160 RSC neurons per animal (median = 46) were longitudinally registered across all days (Psilocybin responders = 460 total neurons; Psilocybin non-responders = 350 total neurons; Saline rapidly-extinguishing mice = 241 total neurons; Saline slowly-extinguishing mice =116 neurons total; Fig. 2e,g,h). Miniscope placements were validated in all mice (Supplementary Fig. 2).
All miniscope mice successfully acquired TFC and were subsequently split into psilocybin (1.0 mg/kg; i.p.; n=14 mice) and saline (n=7 mice; Fig. 2f left, Supplementary Table 1). Miniscope implanted mice extinguished less robustly than surgically naïve mice, indicating an impact either of head trauma or chronic stress post-implantation on TFC extinction (Fig. 2f right, Supplementary Table 1). Nonetheless, by Extinction 3, a subset of psilocybin responders emerged. Seven of fourteen psilocybin-treated mice and three of seven saline-treated mice extinguished their freezing by over 50% (Fig. 2f, Supplementary Table 1).
RSC neurons are modulated over TFC training.
To determine changes in the task-relevant response properties of RSC neurons, fractions of tone-, trace, shock-, and tone+trace-responsive neurons were measured each day (Fig. 2i). Fractions of tone- or trace period-upregulated neurons were not significantly affected over time in any treatment group and in general varied between 10-30% of neurons (Fig. 2j,k, Supplementary Table 1). ~40% of recorded RSC neurons were shock-responsive neurons (Fig. 2l, Supplementary Table 1). On average, ~50% of tone-responsive neurons on a given day were also trace-responsive on the same day, suggesting a high degree of overlap of activated neurons between different periods in a trial (Fig. 2m, Supplementary Table 1). There was a large rate of turnover in tone- and trace-responsive neurons between days, with ~75% of tone- and ~60% trace-responsive neurons maintaining their responsiveness for only 1 day and about ~25% and ~30% respectively for 2 days across groups (Fig. 2n,o, Supplementary Table 1).
Similar proportions of all neurons recorded were responsive to various stimuli on each day, indicating that the longitudinally registered neurons subsequently used for analysis comprise a sufficiently representative sample of all recorded neurons. (Supplementary Fig. 2c–j, Supplementary Table 1). Within days, the proportion of total shock- and stable tone-and-trace responsive neurons during Extinction 1 positively correlated with freezing in early Extinction 3 in psilocybin mice, and suppressed shock-responsive neurons during Extinction 1 correlated with freezing in early Extinction 3 in saline mice, suggesting that neural response properties during Extinction 1 may be related to behavioral extinction across groups.
Psilocybin alters dynamics and encoding of freezing behavior.
The RSC was host to many neurons encoding freezing behavior in every session (Supplementary Fig. 2b, Supplementary Table 1). Interestingly, the average freezing encoding of individual neurons increased during Acquisition, suggesting that RSC neurons preferentially encode acute fear-related freezing (Fig. 2p,q, Supplementary Table 1). Behaviorally, psilocybin significantly reduced bout number and increased bout length acutely during Extinction 1 without affecting total freezing time, indicating an effect of psilocybin treatment on the ability to maintain sustained freezing (Fig. 3a,b, Supp Fig. 3, Supplementary Table 1). This could be due to an interruption of attention to or recall of fear cues.
In non-longitudinally registered neurons, transitions from freezing to motion and vice versa were robustly encoded in the first 3 PCs of RSC activity (Fig. 3c). Average Euclidean distance from freezing-to-motion and motion-to-freezing trajectories tended to be stable within this time window. However, distance greater during Extinction 1 in rapidly compared to slowly extinguishing saline mice, a difference occluded by psilocybin (Fig. 3d, Supplementary Table 1). Accordingly, single cell discriminability between freezing and motion, in terms of the population’s median magnitude of d-prime, was suppressed by psilocybin (Fig. 3e, Supplementary Table 1). Interestingly, population freezing was subsequently enhanced in responders during Extinction 3 and predicted freezing levels in psilocybin but not saline mice (Fig. 3d,f, Supplementary Table 1). Thus, while RSC discriminability between motion and freezing during Extinction 1 is enhanced in rapidly extinguishing mice, psilocybin acutely suppresses this neural discriminability preceding its rebound 48 hours later in responders. Psilocybin therefore interrupts freezing behavior and encoding in mice.
Tensor component analysis reveals evolution of RSC through different states over fear and extinction learning.
We hypothesized that psilocybin induces the rapid recruitment of a novel Extinction associated ensemble in the RSC during Extinction 1 that persistently drives RSC activity during future extinction sessions. Enhanced extinction could also arise from psilocybin-mediated suppression of specific ensembles associated with the fear learning and memory. To identify ensembles associated with TFC acquisition and extinction, we employed an unsupervised dimensionality reduction technique developed by Williams et al., 2018 called Tensor Component Analysis (TCA) that can be used to group neurons into functional ensembles defined by their within- and across-trial dynamics 73 (Fig. 4a).
To determine the appropriate model rank for analysis, TCA was run on cells pooled from all animals in each treatment group to calculate model reconstruction error and similarity as a function of increasing model rank. The elbow method revealed that models of rank 5 were most appropriate for subsequent analysis, and such models were generated for individual animals (Fig. 4c) Across animals, rank 5 models did not identify within-trial temporal dynamics beyond shock-responsiveness (Supplementary Fig. 3a–e, Supplementary Table 1). They did, however, cluster trials from the same session, identifying RSC dynamics driving distinct phases of TFC acquisition and extinction (Fig. 4a,b).
To eliminate the possibility that trial clustering was due to changes in recording quality between days or cell misalignment, 100 iterations of TCA on the real data from each group were compared to TCA models of 100 shuffles of the neural activity. Neural activity was shuffled by cells at each timepoint, such that the average activity over time and trials was preserved. This way, differences in between- and within-trial temporal dynamics of the entire population would be entirely conserved, but the ensembles driving those differences would be abolished.
To calculate the session discriminability of the real and shuffled TCA models, we exploited the clustering of trial factor weights within a given session, yielding a dominant component for each session. In a model of rank R, for component r in session s with mean trial weights , the relative strength of each component. The model’s subsequent session discriminability index were calculated as:
When cells were shuffled to preserve the within- and across-trial structure of the data, session discriminability was significantly diminished in every group, rejecting the hypothesis that same-session trial clustering was due to recording or registration artifacts (Fig. 4d, Supplementary Table 1). In non-shock control mice, who did not undergo any associative learning beyond neutral sensory integration and context familiarization (i.e., no electric shocks during Day 2 Acquisition), session discriminability was reduced, suggesting TCA identified task-relevant components of RSC activity (Supplementary Fig. 5a–d, Supplementary Table 1).
In conditioned mice, the relative strength of each component strongly also predicted freezing across and within their own session with R2 > 0.1 (Fig. 4e,f, Supplementary Table 1). The strength of the Acquisition-dominant component during Acquisition and Extinction 3 oppositely predicted freezing, while the Extinction 3-dominant component during Extinction 3strongly predicted extinction rate across groups, suggesting the identification of fear extinction related neural dynamics in the RSC by TCA (Fig. 4g, Supplementary Table 1). These results confirm that the evolution through unique dynamics across days is a learning-related process in the RSC.
Turnover in the dominant neural ensembles driving RSC dynamics predicts fear extinction.
The neuron factor weights returned by TCA were used to identify ensembles driving the Acquisition-, Extinction 1-, and Extinction 3-dominant components of RSC activity in each mouse. When simulated tensors for each animal populated with identically behaving neurons, the mean and median weights were w = 1.0694 and 1.0709 respectively, suggesting that, if all neurons contributed equally, each neuron would be assigned w ~1 (Supplementary Fig. 6d–g). Thus, w=1 was considered a reasonable null hypothesis for the strength of a neuron’s participation in each component, such that if a neuron’s weight was greater than 1, then it was included in the ensemble. 40% of neurons met this criterion for each ensemble, resulting in considerable ensemble overlap (Fig. 5a,b, 6a, Supplementary Fig. 4a–c, Supplementary Table 1). Ensemble overlaps are of interest as cells driving RSC dynamics on both Acquisition and Extinction 1, for instance, might in part comprise a neural substrate for a fear memory61.
Intriguingly, although every combination of these ensembles (Acq-Only, Ext1-Only, Ext3-Only, Acq/Ext1, Acq/Ext3, Ext1/Ext3, and Acq/Ext1/Ext3) were represented rapid saline mice, slow saline mice failed to recruit any new dominant neurons in Extinction 1, resulting in a large Acq/Ext1/Ext3 ensemble and smaller Acq/Ext1 and Ext3-only ensembles (Fig. 5b, Supplementary Table 1). Rapidly extinguishing mice recruited a new Extinction 1-dominant ensemble and suppressed a portion of the Acquisition dominant ensemble (19%, Acq-only neurons). However, slowly extinguishing mice did neither until Extinction 3, where only 25% of neurons were recruited compared to 55% in rapidly extinguishing mice. The proportion of Acq/Ext1/Ext3 neurons strongly predicted extinction rate in saline mice, confirming the interpretation that ensemble turnover is associated with effective fear extinction (Fig. 5c, Supplementary Table 1).
Tracking the change in activity in these ensembles from Acquisition revealed that slowly extinguishing mice display blunted plasticity in the Ext3-only and Acq/Ext1 neurons compared to rapidly extinguishing mice (Fig. 5d,e, Supplementary Table 1). While Acq/Ext1/Ext3 neurons are significantly more activated during Extinction 1 and Extinction 3, rapid mice display a strong enhancement of Acq/Ext1 and Ext3-only activity during Extinction 1 and 3 respectively, while Acq/Ext1 neurons are maintained, and Ext3-only neurons weakly enhanced in slowly extinguishing mice. Instead, an enhancement Acq/Ext1/Ext3 activity appears to be the defining feature of RSC activity in slow-extinguishing mice (Fig. 5f, Supplementary Table 1). Thus, both in terms of neuronal identity and activation, plasticity in dominant RSC ensembles appears to be a feature of effective TFC extinction.
Psilocybin enhances extinction-associated ensemble turnover.
Both responders and non-responders exhibited high ensemble turnover, in contrast to slowly extinguishing saline mice. To investigate the effect of psilocybin on plasticity of RSC ensembles, responders and non-responders are compared only to rapid saline mice, due to the nonexistence of these ensembles in slowly extinguishing mice. Ensemble overlaps significantly differed between psilocybin and rapid saline mice in most cases, but not between responders and non-responders (Fig. 6a top, Supplementary Table 1). The overlap between Acq- and Ext1-dominant neurons was similar across all groups. Non-responders exhibited the greatest proportion of Acq/Ext1/Ext3 neurons, while rapid saline mice exhibited the greatest proportions of Acq/Ext1 and Acq/Ext3 neurons. Responders displayed the greatest proportion of Acq-only neurons, the only ensemble defined by its persistent suppression during both Extinction 1 and Extinction 3. Though only a greater proportion of the Ext1-dominant ensemble is defined by newly recruited neurons in psilocybin mice than in rapid saline mice, (Fig. 6a middle). Psilocybin mice recruited double proportion of Ext1/Ext3 neurons. Finally, while more neurons were newly recruited in the Ext3-dominant ensemble in rapid saline mice, similar proportions of neurons had been recruited after Acquisition (Fig. 6a bottom, Supplementary Table 1). The proportion of Ext1/Ext3 neurons comprising the Extinction 3-dominant ensemble was triple that of saline mice in psilocybin mice. Thus, psilocybin acutely accelerates a rapid turnover from fear Acquisition-dominating neurons to a stable Extinction-dominant population. This result is highly consistent with the hypothesis that psilocybin both establishes and stabilizes novel neural ensembles. In non-shock controls, the proportion of Acq/Ext1 and Acq/Ext1/Ext3 neurons was much smaller than in saline mice, while there were more Ext1/Ext3 neurons. (Supplementary Fig. 5e–g, Supplementary Table 1). These result supports the hypothesis that preferential overlaps of Acq/Ext1- and Ext1/Ext3-dominant ensembles, in saline and psilocybin mice respectively, indicate enhanced stability of fear acquisition- and extinction-related ensembles over time.
Activity in neural ensembles predicts treatment and responder status.
Fisher linear decoders were trained to distinguish between psilocybin responders, non-responders, or saline mice based on the average activities of each identified ensemble during either Extinction 1 or Extinction 3 (Fig. 6b, Supplementary Fig. 4d–e). Decoders were trained to classify two groups at a time – responders vs. non-responders, responders vs. saline, non-responders vs. saline to determine which ensembles varied with treatment, extinction class, or both.
During Extinction 1, when psilocybin mice were under acute influence of the drug, the Ext3-Only and Ext1/Ext3 ensembles specifically distinguished both groups of psilocybin mice from saline mice, suggesting that psilocybin affected activity in these ensembles in a behavior-nonspecific fashion (Fig. 6b top). The Acq/Ext1 and Acq/Ext3 ensembles discriminated between all groups, suggesting that psilocybin’s acute effects on these neurons can predict future behavioral change. The Acq/Ext1/Ext3 ensemble only dis criminated between responders and the other two groups, suggesting that, while this ensemble is not determinately affected by psilocybin, altered activity in this ensemble during psilocybin administration may enhance future behavioral change. The Acq-Only ensemble significantly distinguished non-responders from the other two groups, suggesting that altered activity in this ensemble under psilocybin may block future behavioral change. During Extinction 3, the Ext3-Only ensemble came to distinguish all three groups (Fig. 6b bottom). These results suggest that psilocybin acutely alters dynamics in these neurons acutely and post-acutely in a manner predicting behavior.
When models were trained on all seven ensembles as predictors, they predicted treatment and responder status with > 95% accuracy on all 100 iterations for each pair (Fig. 6b right). Classification between all three groups verified these results (Supplementary Fig. 4e–f). The ability of many ensembles to distinguish responder status during Extinction 1 suggests that neural activity in the RSC during psilocybin exposure may be a crucial determinant of therapeutic-like response 48 hours later.
Acute suppression of Acq-dominant neurons and delayed recruitment of Ext3-dominant neurons predict psilocybin-enhanced extinction.
To explore the development of the distinctive predictive characteristics of each ensemble, we calculated how the activity of each neuron in these ensembles changed from the Acquisition session. Acq-Only neurons were suppressed during Extinction 1 and Extinction 3 in all groups, but significantly less so in non-responders, suggesting that the suppression of this ensemble during early extinction may affect the pace of fear extinction in mice (Fig. 6c, Supplementary Table 1). Ext1-Only neurons were potentiated in all groups during Extinction 1, but only remained significantly greater than zero during Extinction 3 in responders (Fig. 6d, Supplementary Table 1).
However, this ensemble had limited predictive abilities regarding both responsiveness and treatment, weakening the claim that this difference is crucial for psilocybin’s effects on TFC extinction. Ext3-Only neurons were strongly recruited in all groups in Extinction 3, but significantly more greatly in responders, suggesting that this enhanced activation of Ext3-Only neurons 48 hours after drug administration may drive enhanced TFC extinction in responders (Fig. 6e, Supplementary Table 1).
Acq/Ext1 neurons were significantly suppressed during Extinction 1 in responders, unchanged in non-responders, and enhanced in rapidly extinguishing mice, underlying this ensembles’ ability to distinguish between all three groups (Fig. 6f, Supplementary Table 1). This result suggests that, although psilocybin results in the suppression of Acq/Ext1 neurons 48 hours after drug administration in both responders and non-responders, it may only ultimately enhance extinction when Acq/Ext1-dominant neurons are suppressed during acute drug effects. The Acq/Ext3-dominant ensemble was significantly suppressed in Extinction 1 in all animals, and subsequently strongly potentiated with respect to Acquisition levels in Extinction 3 in responders and rapid saline mice, suggesting that these neurons were suppressed during acute drug effects and subsequently re-recruited in responders (Fig. 6g, Supplementary Table 1). Likewise, the Ext1/Ext3-dominant ensemble was potentiated across days with respect to Acquisition in all groups, but most greatly in rapid saline mice, potentially compensating for its reduced numbers in saline mice (Fig. 6h, Supplementary Table 1). Finally, the Acq/Ext1/Ext3 ensemble driving activity in all three sessions was suppressed during Extinction 1 in responders but potentiated in non-responders and saline mice (Fig. 6i, Supplementary Table 1). This result suggests that acute suppression of this ensemble during psilocybin administration may enhance the likelihood of enhanced TFC extinction.
For a holistic picture of these results, one can consider the entire Acq-, Ext1-, and Ext3-dominant ensembles. In saline mice, the Acq-dominant ensemble is persistently active at Acquisition-like levels throughout Extinction, regardless of extinction rate (Fig. 7b, Supplementary Table 1). This result is specific to TFC-trained mice, as opposed to non-shock mice, indicating the persistence of a potential substrate for fear memory throughout extinction in saline mice (Supplementary Fig. 5h, Supplementary Table 1). In contrast, psilocybin persistently suppresses the Acq-dominant ensemble, strongly in responders and weakly in non-responders (Fig. 7b, Supplementary Table 1). The Ext1-dominant ensemble is potentiated throughout extinction in all groups, though most in rapid mice due to the lack of inhibition of overlapping Acq-dominant neurons, unlike psilocybin mice, and the presence of newly recruited neurons, unlike slowly extinguishing mice (Fig. 7c, Supplementary Table 1). Finally, recruitment of the Ext3-dominant ensemble more greatly in saline mice than non-shock controls, suggesting that heightened activity in novel RSC ensembles is a feature of TFC extinction (Fig. 7d, Supplementary Table 1). However, the Ext3-dominant ensemble is most greatly recruited in both responders and rapidly extinguishing saline mice, suggesting that this recruitment is a fixed feature of effective fear extinction in the RSC, regardless of treatment. However, its recruitment was enhanced in psilocybin responders compared to rapid saline mice. Critically, these results were robust to varying the factor loading thresholds determining a neuron’s ensemble membership (Supplementary Fig. 6a–c, h).
To determine the relationship between changes in neural activity and behavior, we regressed percent time freezing in the last half of Extinction 3 on the change in neural activity of the Acq-dominant ensemble during Extinction 1 and the Ext3-dominant ensemble of Extinction 3. (Fig. 7e,f) We found that these variables both significantly and oppositely predicted freezing in psilocybin mice but not saline mice. Thus, psilocybin may enhance TFC extinction in animals by bidirectionally modulating ensembles underlying distinct phases of TFC.
A computational model of a two-ensemble RSC microcircuit explains psilocybin’s effects.
Acq-dominant neurons are largely shock-responsive (Fig. 8a). Ideally, to test their causal influence on psilocybin-enhanced extinction, we would capture and manipulate this functional ensemble, with methods such as TRAP or scFlare paired with opto- or chemogenetics. These approaches require that the targeted neurons have largely homogenous and stable response properties, distinct from the general population, across trials. However, we found that most neurons significantly respond to the shock on only 1-3 of the total 8 trials (Supplementary Fig. 7a,d). Importantly, on each trial, the set of shock-responsive neurons only overlaps by 30-40% with any other trial (Supplementary Fig. 7b), while a similar proportion of the general population are also shock responsive (Supplementary Fig. 7c). Thus, this functional population does not meet the criteria necessary for these techniques, as TRAP or scFlare tagging would be nonspecific and insensitive to Acq-dominant neurons with trial-varying response properties.
Therefore, to determine whether inhibition of the Acq-dominant ensemble by psilocybin could be sufficient to explain either enhanced recruitment of the Ext3-dominant ensemble and/or behavioral variability in extinction, we built a linear-nonlinear firing rate model of a hypothesized RSC microcircuit. Each of the two ensembles was modeled with ten recurrently connected units undergoing Hebbian plasticity, with heterogeneous response properties mimicking the real data. These included eight shock responsive units in the Acq-dominant ensemble and five shock omission-responsive units in the Ext3-dominant ensemble (Fig. 8a,b). Crucially, each ensemble inhibited the other. Psilocybin was simulated as varying amounts of direct synaptic inhibition ranging between 0 and 1.
The average activity of the Acq-dominant units spiked during each shock-delivery and increased over Acquisition (Fig. 8c). Under no and low amounts of psilocybin inhibition, Acq-dominant units also spiked during the first trial of Extinction 1 before gradually reducing their activity over time, demonstrating successful modeling of fear conditioning (Fig. 8c, panels 1 & 2). Subsequently, the shock-omission-sensitive Ext3-dominant ensemble elevated its activity over Extinction. This result demonstrates that the recruitment of Ext3-dominant neurons over extinction is a feature of this mutually inhibitory circuit, as our data suggest.
At the highest dose of inhibition and in the positive control case of entirely ablating inputs to the Acq-dominant ensemble, the conditioned response of the Acq-dominant ensemble during Extinction 1 is eliminated and activity of the Ext3-dominant ensemble is enhanced in Extinction 3 (Fig. 8c, panels 3 & 4). Therefore, inhibition of Acq-dominant ensembles is sufficient to explain enhanced recruitment of Ext3-dominant neurons.
To determine whether the assumptions in this model are necessary for its validity, we assessed the activity changes of the ensemble while systematically varying underlying assumptions about the circuit’s architecture (Fig. 8d). Importantly, for the model to be valid, the case of no inhibition must account for saline mice who undergo recruitment of Ext3-dominant ensemble without inhibition of the Acq-dominant. This criterion rules out every case other than our full model, where Acq- and Ext3-dominant ensembles are defined as excitatory populations that mutually inhibit one another.
To determine how well our full model explains our results, we plotted the activity of the Ext3-dominant ensemble during Extinction 3 as a function of that of the Acq-dominant ensemble during Extinction 1 alongside the average values of each mouse (Fig. 8e). The model predicts that there is a nonlinear relationship between inhibition of Acq-dominant neurons and recruitment of Ext3-dominant neurons, comprised of a shallow quasi-linear part ranging over lower inhibition and a steep quasi-linear part ranging over greater inhibition. To determine which part fits psilocybin or saline data, we calculated the slopes of these lines and the mean squared error (MSE) to our real data (Fig. 8f) We found that while both parts strongly fit the psilocybin data, they more weakly fit the saline data, as expected. Compellingly, while the high inhibition part fit the psilocybin data best (MSEhigh inhibition = 1.5127, MSElow inhibition = 1.8298), the low inhibition part fit the saline mice better (MSEhigh inhibition = 5.2465, MSElow inhibition = 2.9801). These results are consistent with our observations that 1) inhibition of Acq-dominant ensembles is only partially present in rapid mice, while it is a consistent phenomenon in psilocybin mice (Fig. 6c–i) and 2) degree of inhibition of Acq-dominant neurons is only related to degree of subsequent recruitment of Ext3-dominant neurons in psilocybin mice (Fig. 7b–d).
Finally, to determine whether the model explains the distribution of behavioral variability of freezing in late Extinction 3, we calculated the simulated z-score % freezing using the multiple regression model from Fig. 7e,f (Fig. 8g). Indeed, we found that the steep, high inhibition part of the model explains the reduction of freezing in responders as a function of mean inhibition of the Acq-dominant ensemble and the failure do so in non-responders, with the predicted freezing lying within a standard deviation of the mean values for each group.
Discussion.
In this study, we combined in-vivo single cell calcium imaging of cortical ensembles with behavioral pharmacology to elucidate the neural correlates of psilocybin-enhanced extinction. The existence psilocybin-responsive and non-responsive subpopulations of humans and rats has been the subject of recent investigation28,75. Here, we report for the first time that mice are divided into psilocybin responsive and non-responsive groups with respect to post-acute enhancement of TFC extinction. In drug-responsive animals, psilocybin enhances expression of extinction 24 and 48 hours later. In non-responsive animals, psilocybin has no effect on behavior compared to extinction rate-matched saline animals. Acutely, psilocybin increased freezing bouts while decreasing freezing length, suggesting an acute disruption of attention or recall processes. In miniscope-implanted mice, these behavioral changes were accompanied by a reduction of single cell and population-level discriminability between freezing and motion, raising the intriguing possibility that psilocybin could acutely impair the perception of self-motion. Freezing-encoding then recovered in Extinction 3 and predicted freezing in psilocybin mice, suggesting that recovery of freezing encoding is a biomarker of effective psilocybin-modulated fear extinction.
We used TCA to identify trial-varying components of neural activity associated with fear extinction and putative task-relevant ensembles73. Consistent with the hypothesis that the RSC preferentially encodes the cognitive or behavioral context associated as opposed to explicit sensory events, the trial factor weights of these components tended to cluster trials from the same session without clear organization of the temporal factor weights across animals, a characteristic significantly reduced in non-shock controls. As the RSC is also involved in contextual fear conditioning and may therefore exhibit similar neural correlates in both paired and unpaired conditioning protocols, non-shock controls isolate fear acquisition- and extinction-related signals from those associated with neutral contextual novelty, exploration, and integration39–71.
The RSC generates, hosts, and updates engrams for consolidated fear and extinction memory. For instance, freezing can be evoked in a novel context by optogenetically reactivating RSC-tagged neurons that were initially active during fear learning in another context (i.e., akin to the Acquisition session responsive cells)51,56. In the present study, candidate neurons for engrams related to fear recall and extinction should be comprised of overlaps between the Acq-, Ext1-, and Ext3-dominant ensembles, such that a subset of Acq/Ext1 and Acq/Ext1/Ext3 ensembles participates in a fear engram, while a subset of Ext1/Ext3 or Ext3-only neurons comprise an extinction engram. The behavioral relevance of these ensembles is demonstrated by accurate decoding between responders, non-responders, and rapid saline-treated mice based on each ensemble’s activity.
Consistent with previous findings and as the RSC is necessary for TFC, we found a high proportion of overlapping Acq/Ext1 and Acq/Ext1/Ext3 neurons in saline mice61. Intriguingly, psilocybin reduced this proportion, while the dominant ensembles in slow saline mice were solely comprised of these neurons. The predominance of these ensembles at the expense of Acq-only, Ext1-only, and Ext1/Ext3 neurons in slowly extinguishing saline mice, and the predictive power of the proportion of Acq/Ext1/Ext3 neurons over extinction rate in saline mice, support the interpretation that the maintenance of fear experience-dominating neurons maintains fear-related behavior. The reduction in putative “fear memory” neurons in psilocybin mice resulted in a doubling of Acq-Only neurons, suggesting that psilocybin induced a robust turnover in the composition of the ensembles driving RSC activity in the Extinction 1 session. Finally, a greater proportion of Ext1/Ext3 neurons were observed in psilocybin than saline mice, suggesting that the ensembles recruited under psilocybin were more stable in the days to come. This observation agrees with dendritic and synaptic plasticity studies that demonstrate psilocybin rapidly induces the formation and subsequent long-term stabilization of behaviorally relevant neural pathways. However, the lack of association between size of these ensembles with extinction rate ruled out the possibility that ensemble turnover alone influences psilocybin responsiveness.
Previous work showed that that novel ensembles are recruited in the RSC during fear extinction56. Indeed, we observed a substantial recruitment of neurons unique to the Ext3-dominant ensemble in all groups, with significantly lesser activation in non-shock mice. These neurons were significantly more strongly activated during Extinction 3 in psilocybin responders than in any other group. However, this recruitment was preceded by the acute and robust inhibition of Acq-dominant neurons in psilocybin responders that was strikingly absent in saline mice. We found that both the overall inhibition of the Acq-dominant ensemble during psilocybin administration and the subsequent recruitment of Ext3-dominant neurons during Extinction 3 strongly predicted freezing in late Extinction 3 in psilocybin mice, but not saline mice. Furthermore, by modeling these ensembles as mutually inhibitory populations comprised of excitatory neurons, we not only replicated the neural dynamics observed in saline mice but demonstrated that varying the acute inhibition of Acq-dominant neurons during Extinction 1 is sufficient for enhanced recruitment of the Ext3-ensemble and extinction in principle.
All other versions of the model where the underlying assumptions of circuit architecture were altered failed to explain the recruitment of Ext3-dominant neurons in the absence of Acq-dominant inhibition observed in saline mice. Therefore, we can conclude that 1) Acq- and Ext3-dominant ensembles are likely poly-synaptically, mutually inhibitory excitatory populations in the RSC and 2) the inhibition of Acq-dominant neurons is sufficient to explain neural and behavioral variability in our task in response to psilocybin. Given all mice received the same dose of psilocybin, these results raise the exciting possibility that individual differences in receptor availability or circuit anatomy in the RSC facilitate psilocybin-enhanced fear extinction.
These results complicate the prevailing hypotheses in the field that psilocybin’s effects on behavioral flexibility are downstream of excitatory activity and plasticity enacted via 5HT2ARs8. To the contrary, we observed no increased activity under acute psilocybin. As the RSC is rich in 5HT2CRs and 5HT1Ars, both inhibitory with high binding affinity to psilocin, it is plausible that psilocin directly inhibits neurons in this region28,60,61,76. Alternatively, psilocin could excite inhibitory neurons upstream of Acq-dominant neurons to exert its effects. Therefore, it is possible that behavioral variability under psilocybin in this task could be due to variability in receptor expression and availability or in anatomical connectivity.
Identifying these neurons will be key to establishing their causal influence on fear extinction with or without psilocybin and potentially developing targeted therapeutics. One possibility is that these neurons are salience or valence-sensitive. Notably, a single-dose of psilocin reduces neural activities to aversive airpuffs in the central amygdala days later, hinting that weakened neural activities within negative valence-encoding circuits may partially contribute to this observation77. In the RSC, our data and model suggest that Acq- and Ext3-dominant ensembles contain neurons responsive to shock or shock omission, stimuli of opposite valence. Furthermore, our observations echo the finding that inhibitory plasticity in hippocampus fear memory engrams is necessary for the development memory selectivity, measured by the reduction of freezing in neutral contexts over time78. As RSC neurons can encode changes in reward values47,48, ensembles in this study could constitute a valence- or salience-sensitive ensembles in the RSC, a feature that can enable their genetic and anatomical identification. Taken together, these results suggest that psilocybin both enhances endogenous mechanisms of fear extinction - the potentiation of newly recruited RSC neurons - and, or possibly because, it engages non-typical mechanisms as well - the suppression of fear acquisition-dominating neurons in drug responders. These results support a current field hypothesis that the neurophysiological effects of psychedelics underlying behavioral flexibility involve altering task-relevant activity in neural ensembles over subsequent days79. However, rather than simply accelerating or enhancing endogenous mechanisms of behavioral flexibility (i.e., increasing activity in new ensembles), psilocybin also engages an inhibitory mechanism of fear extinction. Indeed, the acute, response-predicting effects of psilocybin observed in this study are entirely comprised of inhibition of fear acquisition-associated neurons. Psilocybin’s enhancement of extinction-like activity is not observed until the days following treatment and can be explained by prior suppression of fear memory-associated activity. Future research will explore how the neuroplastic effects of psilocybin on a cellular and circuit level evoke these distinct effects on neural dynamics and establish a causal relationship between the ensemble-specific changes in activity observed here with behavior.
Methods.
Experimental Methods.
Animals:
Animals used in all studies were C57BL/6J mice Animals: Animals used in all studies were C57BL/6J mice from Jackson Laboratories (RRID: IMSR_JAX:000664). Mice were kept on a reverse 12-hour light/dark cycle. Behavior was performed at least 1 hour and no more than 4 hours following lights-off. Group-housed males (n=34) and females (n=16) between 8-12 weeks of age were used in the behavioral pharmacology experiment in Fig. 1. For the Miniscope study, males of 8-10 weeks of age underwent viral injection surgeries, followed by implantation of 4.0 (length) x 1.0mm (diameter) GRIN lens at 10-12 weeks, and behavior at 12-16 weeks (minimum 2-week recovery time from last surgery). Mice were singly housed following implant surgery.
TFC Conditioning and Extinction:
One week prior to behavioral testing, Miniscope mice were habituated to the Miniscope for 2 days in 10 min sessions in the home cage. All mice underwent behavioral training and testing in Med Associates fear conditioning boxes for five days. In Context A, Med Associates chambers were equipped with smooth white floor inserts and cleaned with ethanol to provide a unique olfactory, tactile, and visual context. In Context B, the shock grid floor was exposed, mouse bedding was placed in a tray under the floor, and chambers were cleaned with Clidox. The five days of behavioral testing consisted of Habituation (Hab), Acquisition (Acq), and Extinction 1-3 (Ext1-3). Hab and Ext1-3 took place in Context A, and Acquisition took place in Context B. The CS consisted of a 4kHz, 75dB tone delivered in 25, 200ms pips at 1Hz. During Acquisition, the CS was followed by a 20sec trace period preceding a 1mA, 2sec shock. On all other days, the shock was omitted. Habituation and Acquisition consisted of 8 trials, with jittered ITIs of 60±10sec. During Extinction 1-3, there were 6 trials per session. 30 minutes prior to Extinction 1, mice were injected with 1mg/kg psilocybin, contributed by the Elizabeth Heller Laboratory at the University of Pennsylvania, or saline. Mice were excluded from the study if they froze ≤20% of the time during Acquisition or ≤10% of the time during the first half of Extinction 1 (n=23 mice, Supplementary Fig. 1D). Two mice were excluded due to excessive barbering in the home-cage during the days of the experiment.
For Miniscope studies, a 2”-diameter hole was drilled in the top of a Med Associates box to feed the cables through. During the sessions, recordings were remotely controlled and streamed to a laptop for live monitoring. Recordings were made at LED power (0.7-1.5mW), gain (1.0-3.0), and focus (0-300μm) settings deemed appropriate for each mouse and kept as consistent between recording days as possible.
For the non-shock control condition, Miniscope-implanted mice underwent an identical protocol, except for the total omission of the shock.
Surgery:
For Miniscope studies, all mice were unilaterally injected with 800nL of AAV9-syn-GCaMP8m-WPRE at a titer of 1.2e12 (Addgene virus #162375) in the RSC. RSC coordinates were chosen from past studies: −2.25 AP, +0.3ML,−0.8 DV. Mice were anesthetized with isoflurane. Hair was removed with Nair, and the skin sterilized with Betadine and ethanol. An incision was made with scissors along the scalp. Tissue was cleared from the skull surface using an air blast. The skull was leveled such that the Bregma-Lambda and ML DV difference was within ±0.1mm. A craniotomy was made at the chosen coordinates with a dental drill. A needle was lowered to the target coordinates through the craniotomy and virus infused at 100nL/min. The needle was left in the brain 10mins after infusion before being slowly withdrawn. The incision was sutured, and the animal was administered Meloxicam before being placed under a heat lamp for recovery.
Miniscope implantation surgeries subsequently followed the same protocol until the craniotomy step. A 1mm craniotomy was made by slowly widening the craniotomy with the dental drill. Dura was peeled back using microscissors, sharp forceps, and curved forceps. The craniotomy was regularly flushed with saline, and gel foam was applied to absorb blood. An Inscopix Pro-View Integrated GRIN lens and baseplate system was attached to the Miniscope and a stereotax. Using the Inscopix stereotax attachment, the lens was slowly lowered into a position over the injection site. The final DV coordinate was determined by assessing the view through the Miniscope stream. If tissue architecture could be observed in full focus with light fluctuations associated with RSC slow oscillatory activity under anesthesia, the lens was implanted at that coordinate (−0.6 to −0.3DV). The GRIN lens + baseplate system was secured to the skull with Metabond and then dental cement. After surgery, mice were singly housed and injected with Meloxicam for three consecutive days during recovery.
Miniscope validation:
Before admission to the experiment, the miniscope was magnetically attached to each animal’s implant for habituation and streamed using the Inscopix Data Acquisition Software. If many cells could be observed during spontaneous behavior in the home cage, the mouse was admitted. If only a few cells were visible, the session was recorded and analyzed in the Inscopix Data Processing Software (IDPS) to determine the number of observable cells. If an animal had >20 identifiable cells, they were admitted into the study. Others were euthanized.
Histology:
Animals were perfused with 10% formalin and brains dissected. Brains were stored in formalin solution for 24 hours before being transferred to 30% sucrose. Brains were sectioned at 50μm on a cryostat and stored in PBS. RSC sections were stained with DAPI and sections from −2.18AP to −2.88AP were mounted on slides. The section with the deepest and widest GRIN lens track was designated as the coordinate of implant.
Analysis Methods.
Behavioral:
Behavior was recorded by Basler cameras into Pylon Viewer at 15Hz. Videos were then processed in the open source ezTrack Jupyter Notebook. The algorithm was calibrated to the standard light fluctuations in the empty chambers and the empty chambers with the Miniscope wire dangling in them for each respective study. A freezing threshold was determined in terms of number of pixels changed/frame by visually validating portions of videos classified as “Freezing” or “Moving” by the algorithm. In general, a freezing threshold of 50-200pixels/frame was used in non-Miniscope studies, whereas a threshold of 300pixels/frame was used in all Miniscope animals, necessitated by movements of the Miniscope wire. An animal was only classified as “Freezing” if the pixels/frame remained below threshold for at least 1sec, or 15 frames. Freezing status per frame was exported in a CSV file and post-processed in Matlab to calculate % freezing windows of time. Freezing plotted here is % freezing during the trace period, as this is the interval of time invoking the RSC for fear and extinction encoding and retrieval. Freezing videos were aligned to trial times by beginning analysis at the first frame of the red light in the Med Associates boxes switching on, indicating session start. Although tone delivery times were pseudo-random with respect to the animals, they were hard-coded by the experimenter, so analysis alignment to session start was sufficient to align video to tone.
Calcium imaging pre-processing:
Videos were downloaded from the Inscopix Data Acquisition Box and uploaded to the Inscopix Data Processing Software (IDPS). Videos were spatially downsampled by a factor of 4 and spatial bandpass filtered between 0.005 and 0.500. Videos were then motion corrected with respect to their mean frame. Cells were identified and extracted using CNFM-E (default parameters in the Inscopix implementation of CNMF-E, except the minimum in-line pixel correlation = 0.7 and minimum signal to noise ratio = 7.0) and second-order deconvolved using SCS. Videos across 5 days of behavioral training were longitudinally registered in IDPS (minimum normalized cross-correlation = 0.1). Only cells registered on all 5 days were considered for further analysis.
Calcium imaging post-processing:
Most subsequent analysis was performed in custom Matlab scripts, available in the associated GitHub. Deconvolved calcium traces of cells from each session were aligned according to their global cell index determined in longitudinal registration. As the window considered for each trial included a 10sec baseline period, a 25sec stim period, a 20 sec trace period, a 2 sec shock/omission period, and 3 sec after, each trial was 60sec. Neural activity was therefore summed within 1 sec time windows. Miniscope recordings were started exactly 30.00sec before behavioral session start, and this information was used to align data to behavior and neural data. To determine whether a cell was stimuli-, trace-, and/or shock-responsive, their baseline period activity was compared to their activity during the period of interest by permutation test in 1000 iterations. The proportion of stim/trace/shock-responsive cells compared to all longitudinally registered cells recorded within an animal was calculated for each session and compared between groups and over time with a Two-Way RM ANOVA. When all recorded cells were considered, proportions of these cells compared to the total population were compared within session across groups with a Two-Way ANOVA. A cell was considered stable if it was responsive in both the first and last two trials of a given session; recruited if it was not responsive in the first two but responsive in the last two; and suppressed if the opposite was true. Pearson’s rho was used to calculate the correlations between the proportion of these cells and total % freezing in a session. To calculate the change of activity in groups of neurons between sessions, activity was z-scored to traces recorded in Acquisition and compared between groups and over time with a Two-Way RM ANOVA. To calculate overlaps between ensembles of neurons, ensembles were identified by TCA (described below) in each animal. Whether these overlaps were small or large was determined by a Wilcoxon rank-sum test comparing the median of each overlap in each group with a 50% threshold. If an ensemble shared significantly <50% of neurons with another, this was considered a small overlap. All statistics were calculated in Prism.
Freezing encoding:
To calculate freezing encoding in single longitudinally registered neurons, neural traces were downsampled from 20 to 15Hz and aligned to a 15Hz binary freezing trace. A binomial GLM was trained on half of the data from each session and evaluated on the other half to generate auROCs. The mean auROC of all neurons in a mouse in each session was reported in the main text. To determine the population encoding of freezing in the RSC, 15Hz activity of each recorded cell was normalized to its maximum. 15Hz PSTHs from 2 seconds before to 2 seconds freezing onset or freezing offset of all cells from each day were averaged over trials and projected into the same principal component space, unique to each animal. The Euclidean distance was calculated between these trajectories at each timepoint and averaged across groups for Fig. 3D and then averaged over time for Fig. 3E. To determine whether changes in freezing encoding in PC space were observable at the single cell level, d-prime was calculated for each neuron over the same motion and freezing time windows used to produce the trajectories. Where a = activity:
Single cell freezing discrimination for each animal was reported as the median of the absolute values of d-prime. These outcomes were compared within sessions between treatment and extinction rate groups with a Two-Way ANOVA.
TCA:
To perform TCA, post-processed calcium imaging data was arranged into tensors tsec x ccells x Ttrials in size for each animal, exported as a Matlab structure, and imported into Spyder where we employed the TensorTools package developed by Williams et al., 2018. To determine the appropriate model rank empirically, TCA was first run on the pooled and aligned tensors from all mice in each treatment group, and model reconstruction error and similarity were plotted as a function of increasing model rank. The elbow method revealed that models of rank 5 were most appropriate for subsequent analysis (Reconstruction error = 0.615; Model similarity between four iterations = 1). Models of rank 5 were then generated for each animal.
To measure the dominance of each of the 5 components during a given trial, the relative strength of a given component was measured as the fraction of the total trial weights at that time assigned to that given component. This measure functions to assess how dominant this component is over others at a certain time. Linear regression was used to determine the relationship between component-dominance and behavior over time.
To determine total extent of session discriminability of TCA-identified components, pooled TCA models were generated 100 times for each group and compared to models generated on 100 shuffled datasets from the same groups using unpaired t-tests. Neurons were randomly shuffled at each timepoint to preserve the within- and across-trial temporal structure of the data, controlling for changes in recording quality across days. To compare across groups, neurons were randomly subsampled in each iteration of TCA to control for effects of the number of cells on session discriminability.
As TCA also assigns weights to each neuron in each component, we found we could use this information to identify ensembles of neurons driving each component.
Identifying neural ensembles:
TCA returns neuron factor loadings signifying the relative weight of each neuron in each component. However, the absolute values of these weights are influenced by the size of the data tensor across all three dimensions. To determine the neuron factor loading or weight above which a neuron would be contributing to a component greater than by chance, simulated data tensors were generated for each animal populated with identically behaving neurons. For animal a with c longitudinally recorded neurons, given a constant experimental structure of T = 34 total trials with t = 60 sec per trial, a tensor of 60 sec x ca x 34 trials was generated and TCA iterated 100x. We chose a threshold of w=1.0 as the median and mean of the null distribution of the factor loading threshold were greater than 1.0 and less than 1.1. Primary outcomes (See Fig. 5B–D, Supplementary Fig. 6) were re-calculated using various factor thresholds to verify that results with a threshold w=1.0 are robust to threshold choice. Thus, Acq-dominant ensemble, for instance, was therefore comprised of neurons with w>1 in the Acq-dominant component determined by the strength metric described above.
Multiple regression:
To determine the predictive power of the observed changes in neural ensemble activity over freezing in late Extinction 3, mean % trace period freezing, mean change in activity from Acquisition of the Acq-dominant ensemble during Extinction 1 and of the Ext3-dominant ensemble during Extinction 3 were all respectively z-scored within treatment condition to normalize the distributions and regressed. Adjusted R2, p values, coefficients, and their 95% confidence intervals are reported.
Fisher linear discriminant analysis:
A Fisher decoder was trained in Matlab on one of seven predictors: the mean activity of the Acq-Only, Ext1-Only, Ext3-Only, Acq/Ext1, Acq/Ext3, Ext1/Ext3, or Acq/Ext1/Ext3 ensembles over all timepoints in each session. Class labels were “Responders,” “Non-responders,” or “Rapid” mice. Fisher decoders were trained to distinguish between data from two of the class labels to determine how similar or different the ensembles between pairs of groups behaved. Fisher decoders were trained on a randomly selected 50% of the data and evaluated on the other 50% over 100 iterations. As a control, class labels were randomly shuffled, and model performance was evaluated on the shuffled data. If the accuracies of the decoders generated by a given ensemble’s activity overlapped with the distribution of accuracies when evaluated on shuffled data, it was classified as failing to predict responder status or treatment. If not, then this ensemble was classified as predictive with respect to the given distinction. To validate the ability to distinguish all three classes based on these ensembles was verified with three-way Fisher decoders in Supplementary Fig. 4.
Computational model:
A linear non-linear firing rate model was composed of a hypothesized RSC microcircuit comprised of Acq- and Ext3-dominant neurons obeying the following system of equations based on the cortical circuit model proposed by Park and Geffen, 202280. To evaluate the activity at time t in neuron I, take the following quantities as time t-1:
Where I is the synaptic input to neuron i, wi,j is the weight of input from neuron j in the same ensemble, wi,o is the weight of input from neuron o in the opposing ensemble, A is the presynaptic neuron’s activity, Wi,s is the neuron’s selectivity matrix for the stimulus, S is the stimulus matrix for tone, trace, and shock/omission inputs, and tau is the time constant (1ms where dt is 1s). F is the function describing the nonlinear part of neural activation, such that subthreshold inputs are scaled by a factor r = 3. The transformed synaptic input F is then added to the neuron’s activity A.
Each ensemble was modeled with 10 recurrently connected units with either selective or mixed-selective response properties mimicking the real data that mutually inhibit neurons of the opposite ensemble. (Acq-dominant ensemble: 80% shock-responsive, 20% tone responsive, 20% trace responsive; Ext3-dominant ensemble: 50% shock-responsive, 30% tone responsive, 40% trace responsive). Intra-ensemble weights underwent excitatory plasticity according to a Hebbian learning rule of where the learning rate alpha = 0.1. Psilocybin was simulated only as 100 increasing amounts of direct synaptic inhibition ranging between 0 and 1.
The model was trained on an identical TFC acquisition and extinction task as the mice, with tone and trace delivery simulated as of 0.1 to their responsive units. Shock or shock omission were modeled as inputs to shock or omission responsive neurons as an input of 1 or −1 respectively, and omission-responsive Ext3-dominant neurons weighted this input with w=−1 to flip the sign. The difference in magnitude between shock and tone or trace inputs is intended to reflect their differing salience. The magnitude of the shock-omission input decreased linearly with each trial after Extinction 1, intended to represent reduced salience of the absence of shock over time.
To test the model, its structure was systematically varied to challenge the following underlying assumptions: 1) to test whether the neural populations are excitatory, the weight matrices between neurons of the same ensemble were set to zero, one by one and then together; 2) to test whether the neural populations were mutually inhibitory, the input weights from one ensemble to the other were set to zero, one by one and then together; 3) to test whether shock-omission sensitivity was required, the weight of shock omission inputs to the Ext3-dominant ensemble was set to zero.
To test whether inhibition of the Acq-dominant ensemble was sufficient to explain our empirical results, psilocybin was simulated as P = 101 evenly incremented values of 0 to 100 and subtracted directly from the synaptic input dI as P*tau for the whole Extinction 1 epoch of training.
To determine the fit between the output activities of the model and the real data, the slopes of their linear parts were calculated using the line equation:
MSE between the real data and each slope was then calculated. To calculate simulated freezing in the model, activities were plugged into the equation yielded from the multiple regression of z-score % freezing on z-score activity of Acq-dominant neurons during Extinction 1 and Ext3-dominant neurons during Extinction 3:
Supplementary Material
Acknowledgements.
This work was funded by NIH NIGMS DP2GM140923 awarded to G.C. We thank the University Laboratory Animal Resources (ULAR) group at the University of Pennsylvania for assistance with rodent husbandry and veterinary support, including all faculty stationed at both the Translational Research Laboratory. Thanks to Dr. Maria Geffen (Penn) for advice on model construction and Stephen Wisser (Penn) for assistance running behavioral experiments. We would also like to thank other members of the Corder Lab, Adrienne Jo (Penn) and Raquel Aiada Sandoval Ortega (Penn), and for critical discussions and advice on behavioral analysis, data visualization, and analysis validation. We would also like to thank Colin Mackey for assistance in customizing various python packages. Finally, we would like to thank the faculty of the Cold Spring Harbor Laboratory course in Neural Data Analysis for critical input on analysis approach.
Footnotes
Declaration of competing interests.
The authors declare no competing interests.
References.
- 1.Hoppen Thole H, Priebe Stefan, Vetter Inja, and Morina Nexhmedin. “Global Burden of Post-Traumatic Stress Disorder and Major Depression in Countries Affected by War between 1989 and 2019: A Systematic Review and Meta-Analysis.” BMJ Global Health 6, no. 7 (July 2021): e006303. 10.1136/bmjgh-2021-006303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Nutt David, and Carhart-Harris Robin. “The Current Status of Psychedelics in Psychiatry.” JAMA Psychiatry 78, no. 2 (February 1, 2021): 121–22. 10.1001/jamapsychiatry.2020.2171. [DOI] [PubMed] [Google Scholar]
- 3.Griffiths R. R., Johnson M.W., Richards W. A., Richards B.D., McCann U., and Jesse R.. “Psilocybin Occasioned Mystical-Type Experiences: Immediate and Persisting Dose-Related Effects.” Psychopharmacology 218, no. 4 (December 2011): 649–65. 10.1007/s00213-011-2358-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Agin-Liebes Gabrielle I, Malone Tara, Yalch Matthew M, Mennenga Sarah E, Ponté K Linnae, Guss Jeffrey, Bossis Anthony P, Grigsby Jim, Fischer Stacy, and Ross Stephen. “Long-Term Follow-up of Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Patients with Life-Threatening Cancer.” Journal of Psychopharmacology 34, no. 2 (February 1, 2020): 155–66. 10.1177/0269881119897615. [DOI] [PubMed] [Google Scholar]
- 5.Aday Jacob S., Mitzkovitz Cayla M., Bloesch Emily K., Davoli Christopher C., and Davis Alan K.. “Long-Term Effects of Psychedelic Drugs: A Systematic Review.” Neuroscience & Biobehavioral Reviews 113 (June 1, 2020): 179–89. 10.1016/j.neubiorev.2020.03.017. [DOI] [PubMed] [Google Scholar]
- 6.Gukasyan Natalie, Davis Alan K, Barrett Frederick S, Cosimano Mary P, Sepeda Nathan D, Johnson Matthew W, and Griffiths Roland R. “Efficacy and Safety of Psilocybin-Assisted Treatment for Major Depressive Disorder: Prospective 12-Month Follow-Up.” Journal of Psychopharmacology 36, no. 2 (February 1, 2022): 151–58. 10.1177/02698811211073759. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Hesselgrave Natalie, Troppoli Timothy A., Wulff Andreas B., Cole Anthony B., and Thompson Scott M.. “Harnessing Psilocybin: Antidepressant-like Behavioral and Synaptic Actions of Psilocybin Are Independent of 5-HT2R Activation in Mice.” Proceedings of the National Academy of Sciences of the United States of America 118, no. 17 (April 27, 2021): e2022489118. 10.1073/pnas.2022489118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Cameron Lindsay P., Patel Seona D., Vargas Maxemiliano V., Barragan Eden V., Saeger Hannah N., Warren Hunter T., Chow Winston L., Gray John A., and Olson David E.. “5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines.” ACS Chemical Neuroscience 14, no. 3 (February 1, 2023): 351–58. 10.1021/acschemneuro.2c00718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Hibicke Meghan, Kramer Hannah M., and Nichols Charles D.. “A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance to Depression.” Psychedelic Medicine, March 3, 2023. 10.1089/psymed.2022.0012. [DOI] [Google Scholar]
- 10.Hernandez-Leon Alberto, Escamilla-Orozco Raúl Iván, Tabal-Robles Aylín R., Martínez-Vargas David, Romero-Bautista Leticia, Escamilla-Soto Gerson, González-Romero Osiris S., Torres-Valencia Martín, and González-Trujano María Eva. “Antidepressant- and Anxiolytic-like Activities and Acute Toxicity Evaluation of the Psilocybe Cubensis Mushroom in Experimental Models in Mice.” Journal of Ethnopharmacology 320 (February 10, 2024): 117415. 10.1016/j.jep.2023.117415. [DOI] [PubMed] [Google Scholar]
- 11.Jones Nathan T, Zahid Zarmeen, Grady Sean M, Sultan Ziyad W, Zheng Zhen, Banks Matthew I, and Wenthur Cody J. “Delayed Anxiolytic-Like Effects of Psilocybin in Male Mice Are Supported by Acute Glucocorticoid Release.” Preprint. Animal Behavior and Cognition, August 14, 2020. 10.1101/2020.08.12.248229. [DOI] [Google Scholar]
- 12.Jones Nathan T., Zahid Zarmeen, Grady Sean M., Sultan Ziyad W., Zheng Zhen, Razidlo John, Banks Matthew I., and Wenthur Cody J.. “Transient Elevation of Plasma Glucocorticoids Supports Psilocybin-Induced Anxiolysis in Mice.” ACS Pharmacology & Translational Science 6, no. 8 (August 11, 2023): 1221–31. 10.1021/acsptsci.3c00123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Takaba Rika, Ibi Daisuke, Yoshida Keisuke, Hosomi Eri, Kawase Ririna, Kitagawa Hiroko, Goto Hirotaka, et al. “Ethopharmacological Evaluation of Antidepressant-like Effect of Serotonergic Psychedelics in C57BL/6J Male Mice.” Naunyn-Schmiedeberg’s Archives of Pharmacology, October 24, 2023. 10.1007/s00210-023-02778-x. [DOI] [PubMed] [Google Scholar]
- 14.Odland Anna U., Kristensen Jesper L., and Andreasen Jesper T.. “Investigating the Role of 5-HT2A and 5-HT2C Receptor Activation in the Effects of Psilocybin, DOI, and Citalopram on Marble Burying in Mice.” Behavioural Brain Research 401 (March 5, 2021): 113093. 10.1016/j.bbr.2020.113093. [DOI] [PubMed] [Google Scholar]
- 15.Wulff Andreas B., Nichols Charles D., and Thompson Scott M.. “Preclinical Perspectives on the Mechanisms Underlying the Therapeutic Actions of Psilocybin in Psychiatric Disorders.” Neuropharmacology 231 (June 15, 2023): 109504. 10.1016/j.neuropharm.2023.109504. [DOI] [PubMed] [Google Scholar]
- 16.Passie Torsten, Seifert Juergen, Schneider Udo, and Emrich Hinderk M.. “The Pharmacology of Psilocybin.” Addiction Biology 7, no. 4 (2002): 357–64. 10.1080/1355621021000005937. [DOI] [PubMed] [Google Scholar]
- 17.Lowe Henry, Toyang Ngeh, Steele Blair, Valentine Henkel, Grant Justin, Ali Amza, Ngwa Wilfred, and Gordon Lorenzo. “The Therapeutic Potential of Psilocybin.” Molecules (Basel, Switzerland) 26, no. 10 (May 15, 2021): 2948. 10.3390/molecules26102948. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Garcia-Romeu Albert, Griffiths Roland R., and Johnson Matthew W.. “Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction.” Current Drug Abuse Reviews 7, no. 3 (2015): 157–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Bremler Rebecka, Katati Nancy, Shergill Parvinder, Erritzoe David, and Carhart-Harris Robin L.. “Case Analysis of Long-Term Negative Psychological Responses to Psychedelics.” Scientific Reports 13 (September 25, 2023): 15998. 10.1038/s41598-023-41145-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Simonsson Otto, Carlbring Per, Carhart-Harris Robin, Davis Alan K., Nutt David J., Griffiths Roland R., Erritzoe David, and Goldberg Simon B.. “Assessing the Risk of Symptom Worsening in Psilocybin-Assisted Therapy for Depression: A Systematic Review and Individual Participant Data Meta-Analysis.” Psychiatry Research 327 (September 1, 2023): 115349. 10.1016/j.psychres.2023.115349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Simonsson Otto, Hendricks Peter S., Chambers Richard, Osika Walter, and Goldberg Simon B.. “Prevalence and Associations of Challenging, Difficult or Distressing Experiences Using Classic Psychedelics.” Journal of Affective Disorders 326 (April 1, 2023): 105–10. 10.1016/j.jad.2023.01.073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Breeksema Joost J, Kuin Bouwe W, Kamphuis Jeanine, van den Brink Wim, Vermetten Eric, and Schoevers Robert A. “Adverse Events in Clinical Treatments with Serotonergic Psychedelics and MDMA: A Mixed-Methods Systematic Review.” Journal of Psychopharmacology (Oxford, England) 36, no. 10 (October 2022): 1100–1117. 10.1177/02698811221116926. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Lewis Candace R., Preller Katrin H., Braden B. Blair, Riecken Cory, and Vollenweider Franz X.. “Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin Experience.” Biomedicines 8, no. 2 (February 18, 2020): [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Halim Haniya J., Burk Bradley G., Fargason Rachel E., and Birur Badari. “Manic Episode Following Psilocybin Use in a Man with Bipolar II Disorder: A Case Report.” Frontiers in Psychiatry 14 (2023): 1221131. 10.3389/fpsyt.2023.1221131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Davis Alan K., Barrett Frederick S., and Griffiths Roland R.. “Psychological Flexibility Mediates the Relations between Acute Psychedelic Effects and Subjective Decreases in Depression and Anxiety.” Journal of Contextual Behavioral Science 15 (January 2020): 39–45. 10.1016/j.jcbs.2019.11.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Doss Manoj K., Považan Michal, Rosenberg Monica D., Sepeda Nathan D., Davis Alan K., Finan Patrick H., Smith Gwenn S., et al. “Psilocybin Therapy Increases Cognitive and Neural Flexibility in Patients with Major Depressive Disorder.” Translational Psychiatry 11, no. 1 (November 8, 2021): 574. 10.1038/s41398-021-01706-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Pacheco Alejandro Torrado, Olson Randall J., Garza Gabriela, and Moghaddam Bita. “Acute Psilocybin Enhances Cognitive Flexibility in Rats.” bioRxiv, January 9, 2023. 10.1101/2023.01.09.523291. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Conn K., Milton L. K., Huang K., Munguba H., Ruuska J., Lemus M. B., Greaves E., Homman-Ludiye J., Oldfield B. J., and Foldi C. J.. “Psilocybin Prevents Activity-Based Anorexia in Female Rats by Enhancing Cognitive Flexibility: Contributions from 5-HT1A and 5-HT2A Receptor Mechanisms.” bioRxiv, December 13, 2023. 10.1101/2023.12.12.571374. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Price Rebecca B., and Duman Ronald. “Neuroplasticity in Cognitive and Psychological Mechanisms of Depression: An Integrative Model.” Molecular Psychiatry 25, no. 3 (March 2020): 530–43. 10.1038/s41380-019-0615-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Zhukovsky Peter, Alsiö Johan, Jupp Bianca, Xia Jing, Guiliano Chiara, Jenner Lucy, Griffiths Jessica, et al. “Perseveration in a Spatial-Discrimination Serial Reversal Learning Task Is Differentially Affected by MAO-A and MAO-B Inhibition and Associated with Reduced Anxiety and Peripheral Serotonin Levels.” Psychopharmacology 234, no. 9 (2017): 1557–71. 10.1007/s00213-017-4569-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Vargas Maxemiliano V., Dunlap Lee E., Dong Chunyang, Carter Samuel J., Tombari Robert J., Jami Shekib A., Cameron Lindsay P., et al. “Psychedelics Promote Neuroplasticity through the Activation of Intracellular 5-HT2A Receptors.” Science 379, no. 6633 (February 17, 2023): 700–706. 10.1126/science.adf0435. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Carhart-Harris R. L., and Friston K. J.. “REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.” Edited by Eric L. Barker. Pharmacological Reviews 71, no. 3 (July 2019): 316–44. 10.1124/pr.118.017160. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Alonso Joan Francesc, Romero Sergio, Mañanas Miquel Àngel, and Riba Jordi. “Serotonergic Psychedelics Temporarily Modify Information Transfer in Humans.” International Journal of Neuropsychopharmacology 18, no. 8 (June 2015). 10.1093/ijnp/pyv039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Ly Calvin, Greb Alexandra C., Cameron Lindsay P., Wong Jonathan M., Barragan Eden V., Wilson Paige C., Burbach Kyle F., et al. “Psychedelics Promote Structural and Functional Neural Plasticity.” Cell Reports 23, no. 11 (June 12, 2018): 3170–82. 10.1016/j.celrep.2018.05.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Olson David E. “Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics.” Journal of Experimental Neuroscience 12 (January 1, 2018): 1179069518800508. 10.1177/1179069518800508. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Shao Ling-Xiao, Liao Clara, Gregg Ian, Davoudian Pasha A., Savalia Neil K., Delagarza Kristina, and Kwan Alex C.. “Psilocybin Induces Rapid and Persistent Growth of Dendritic Spines in Frontal Cortex in Vivo.” Neuron 109, no. 16 (August 18, 2021): 2535–2544.e4. 10.1016/j.neuron.2021.06.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Ly Calvin, Greb Alexandra C., Vargas Maxemiliano V., Duim Whitney C., Grodzki Ana Cristina G., Lein Pamela J., and Olson David E.. “Transient Stimulation with Psychoplastogens Is Sufficient to Initiate Neuronal Growth.” ACS Pharmacology & Translational Science 4, no. 2 (April 9, 2021): 452–60. 10.1021/acsptsci.0c00065. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Du Yingjie, Li Yunfeng, Zhao Xiangting, Yao Yishan, Wang Bin, Zhang Liming, and Wang Guyan. “Psilocybin Facilitates Fear Extinction in Mice by Promoting Hippocampal Neuroplasticity.” Chinese Medical Journal, March 30, 2023. 10.1097/CM9.0000000000002647. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Moliner Rafael, Girych Mykhailo, Brunello Cecilia A., Kovaleva Vera, Biojone Caroline, Enkavi Giray, Antenucci Lina, et al. “Psychedelics Promote Plasticity by Directly Binding to BDNF Receptor TrkB.” Nature Neuroscience 26, no. 6 (June 2023): 1032–41. 10.1038/s41593-023-01316-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Schmitz Gavin P., Chiu Yi-Ting, König Gabriele M., Kostenis Evi, Roth Bryan L., and Herman Melissa A.. “Psychedelic Compounds Directly Excite 5-HT2A Layer 5 Pyramidal Neurons in the Prefrontal Cortex through a 5-HT2A Gq -Mediated Activation Mechanism.” bioRxiv, November 15, 2022. 10.1101/2022.11.15.516655. [DOI] [Google Scholar]
- 41.Vann Seralynne D., Aggleton John P., and Maguire Eleanor A.. “What Does the Retrosplenial Cortex Do?” Nature Reviews Neuroscience 10, no. 11 (November 2009): 792–802. 10.1038/nrn2733. [DOI] [PubMed] [Google Scholar]
- 42.Summerfield Jennifer J., Hassabis Demis, and Maguire Eleanor A.. “Cortical Midline Involvement in Autobiographical Memory.” Neuroimage 44, no. 3 (February 1, 2009): 1188–1200. 10.1016/j.neuroimage.2008.09.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Maguire E A. “Neuroimaging Studies of Autobiographical Event Memory.” Philosophical Transactions of the Royal Society of London. Series B 356, no. 1413 (September 29, 2001): 1441–51. 10.1098/rstb.2001.0944. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Todd Travis P., DeAngeli Nicole E., Jiang Matthew Y., and Bucci David J.. “Retrograde Amnesia of Contextual Fear Conditioning: Evidence for Retrosplenial Cortex Involvement in Configural Processing.” Behavioral Neuroscience 135 (2021): 453–61. 10.1037/bne0000432. [DOI] [PubMed] [Google Scholar]
- 45.Todd Travis P., and Bucci David J.. “Retrosplenial Cortex and Long-Term Memory: Molecules to Behavior.” Neural Plasticity 2015 (2015): 414173. 10.1155/2015/414173. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Miller Adam M P, Serrichio Anna C, and Smith David M. “Dual-Factor Representation of the Environmental Context in the Retrosplenial Cortex.” Cerebral Cortex 31, no. 5 (May 1, 2021): 2720–28. 10.1093/cercor/bhaa386. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Hattori Ryoma, and Komiyama Takaki. “Context-Dependent Persistency as a Coding Mechanism for Robust and Widely Distributed Value Coding.” Neuron 110, no. 3 (February 2022): 502–515.e11. 10.1016/j.neuron.2021.11.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Sun Weilun, Choi Ilseob, Stoyanov Stoyan, Senkov Oleg, Ponimaskin Evgeni, Winter York, Pakan Janelle M. P., and Dityatev Alexander. “Context Value Updating and Multidimensional Neuronal Encoding in the Retrosplenial Cortex.” Nature Communications 12, no. 1 (October 18, 2021): 6045. 10.1038/s41467-021-26301-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Trask Sydney, Ferrara Nicole C., Jasnow Aaron M., and Kwapis Janine L.. “Contributions of the Rodent Cingulate-Retrosplenial Cortical Axis to Associative Learning and Memory: A Proposed Circuit for Persistent Memory Maintenance.” Neuroscience & Biobehavioral Reviews 130 (November 2021): 178–84. 10.1016/j.neubiorev.2021.08.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Trask Sydney, and Helmstetter Fred J. “Unique Roles for the Anterior and Posterior Retrosplenial Cortices in Encoding and Retrieval of Memory for Context.” Cerebral Cortex 32, no. 17 (August 22, 2022): 3602–10. 10.1093/cercor/bhab436. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Sousa André F. de, Cowansage Kiriana K., Zutshi Ipshita, Cardozo Leonardo M., Yoo Eun J., Leutgeb Stefan, and Mayford Mark. “Optogenetic Reactivation of Memory Ensembles in the Retrosplenial Cortex Induces Systems Consolidation.” Proceedings of the National Academy of Sciences 116, no. 17 (April 23, 2019): 8576–81. 10.1073/pnas.1818432116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Mitchell Anna S., Czajkowski Rafal, Zhang Ningyu, Jeffery Kate, and Nelson Andrew J. D.. “Retrosplenial Cortex and Its Role in Spatial Cognition.” Brain and Neuroscience Advances 2 (2018): 2398212818757098. 10.1177/2398212818757098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Brennan Ellen KW, Jedrasiak-Cape Izabela, Kailasa Sameer, Rice Sharena P, Sudhakar Shyam Kumar, and Ahmed Omar J. “Thalamus and Claustrum Control Parallel Layer 1 Circuits in Retrosplenial Cortex.” eLife 10 (June 25, 2021): e62207. 10.7554/eLife.62207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Cheng Ning, Dong Qiqi, Zhang Zhen, Wang Li, Chen Xiaojing, and Wang Cheng. “Egocentric Processing of Items in Spines, Dendrites, and Somas in the Retrosplenial Cortex.” Neuron 0, no. 0 (December 14, 2023). 10.1016/j.neuron.2023.11.018. [DOI] [PubMed] [Google Scholar]
- 55.Carhart-Harris Robin L., Muthukumaraswamy Suresh, Roseman Leor, Kaelen Mendel, Droog Wouter, Murphy Kevin, Tagliazucchi Enzo, et al. “Neural Correlates of the LSD Experience Revealed by Multimodal Neuroimaging.” Proceedings of the National Academy of Sciences 113, no. 17 (April 26, 2016): 4853–58. 10.1073/pnas.1518377113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Wang Guangyu, Xie Hong, Wang Lun, Luo Wenhan, Wang Yixiang, Jiang Jun, Xiao Chun, Xing Feng, and Guan Ji-Song. “Switching From Fear to No Fear by Different Neural Ensembles in Mouse Retrosplenial Cortex.” Cerebral Cortex 29, no. 12 (December 17, 2019): 5085–97. 10.1093/cercor/bhz050. [DOI] [PubMed] [Google Scholar]
- 57.Zhang Kai, Shen Dan, Huang Shihao, Iqbal Javed, Huang Gengdi, Si Jijian, Xue Yanxue, and Yang Jian-Li. “The Sexually Divergent cFos Activation Map of Fear Extinction.” Heliyon 10, no. 1 (January 15, 2024): e23748. 10.1016/j.heliyon.2023.e23748. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Davoudian Pasha A., Shao Ling-Xiao, and Kwan Alex C.. “Shared and Distinct Brain Regions Targeted for Immediate Early Gene Expression by Ketamine and Psilocybin.” ACS Chemical Neuroscience 14, no. 3 (February 1, 2023): 468–80. 10.1021/acschemneuro.2c00637. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Kometer Michael, Schmidt André, Jäncke Lutz, and Vollenweider Franz X.. “Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations.” Journal of Neuroscience 33, no. 25 (June 19, 2013): 10544–51. 10.1523/JNEUROSCI.3007-12.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Liu Shijing, Bubar Marcy J., Lanfranco Maria Fe, Hillman Gilbert R., and Cunningham Kathryn A.. “Serotonin2C Receptor (5-HT2CR) Localization in GABA Neurons of the Rat Medial Prefrontal Cortex: Implications for Understanding the Neurobiology of Addiction.” Neuroscience 146, no. 4 (June 8, 2007): 1677–88. 10.1016/j.neuroscience.2007.02.064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Pompeiano M., Palacios J. M., and Mengod G.. “Distribution of the Serotonin 5-HT2 Receptor Family mRNAs: Comparison between 5-HT2A and 5-HT2C Receptors.” Molecular Brain Research 23, no. 1 (April 1, 1994): 163–78. 10.1016/0169-328X(94)90223-2. [DOI] [PubMed] [Google Scholar]
- 62.Zhang Yajuan, Huang Chu-Chung, Zhao Jiajia, Liu Yuchen, Xia Mingrui, Wang Xiaoqin, Wei Dongtao, et al. “Resting-State Functional Connectivity of the Raphe Nuclei in Major Depressive Disorder: A Multi-Site Study.” NeuroImage Clinical 37 (February 24, 2023): 103359. 10.1016/j.nicl.2023.103359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Corcoran Kevin A., Donnan Michael D., Tronson Natalie C., Guzmán Yomayra F., Gao Can, Jovasevic Vladimir, Guedea Anita L., and Radulovic Jelena. “NMDA Receptors in Retrosplenial Cortex Are Necessary for Retrieval of Recent and Remote Context Fear Memory.” The Journal of Neuroscience 31, no. 32 (August 10, 2011): 11655–59. 10.1523/JNEUROSCI.2107-11.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Corcoran Kevin A., Frick Brendan J., Radulovic Jelena, and Kay Leslie M.. “Analysis of Coherent Activity between Retrosplenial Cortex, Hippocampus, Thalamus, and Anterior Cingulate Cortex during Retrieval of Recent and Remote Context Fear Memory.” Neurobiology of Learning and Memory 127 (January 2016): 93–101. 10.1016/j.nlm.2015.11.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Auguste Anne, Fourcaud-Trocmé Nicolas, Meunier David, Gros Alexandra, Garcia Samuel, Messaoudi Belkacem, Thevenet Marc, Ravel Nadine, and Veyrac Alexandra. “Distinct Brain Networks for Remote Episodic Memory Depending on Content and Emotional Value.” bioRxiv, September 19, 2022. 10.1101/2022.09.16.508241. [DOI] [PubMed] [Google Scholar]
- 66.Todd Travis P., Mehlman Max L., Keene Christopher S., DeAngeli Nicole E., and Bucci David J.. “Retrosplenial Cortex Is Required for the Retrieval of Remote Memory for Auditory Cues.” Learning & Memory 23, no. 6 (June 2016): 278–88. 10.1101/lm.041822.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Fournier Danielle I., Cheng Han Yin, Tavakkoli Armin, Gulledge Allan T., Bucci David J., and Todd Travis P.. “Retrosplenial Cortex Inactivation during Retrieval, but Not Encoding, Impairs Remotely Acquired Auditory Fear Conditioning in Male Rats.” Neurobiology of Learning and Memory 185 (November 2021): 107517. 10.1016/j.nlm.2021.107517. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Kwapis Janine L., Jarome Timothy J., Lee Jonathan L., Gilmartin Marieke R., and Helmstetter Fred J.. “Extinguishing Trace Fear Engages the Retrosplenial Cortex Rather than the Amygdala.” Neurobiology of Learning and Memory 113 (September 2014): 41–54. 10.1016/j.nlm.2013.09.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Trask Sydney, Ferrara Nicole C., Grisales Kevin, and Helmstetter Fred J.. “Optogenetic Inhibition of Either the Anterior or Posterior Retrosplenial Cortex Disrupts Retrieval of a Trace, but Not Delay, Fear Memory.” Neurobiology of Learning and Memory 185 (November 2021): 107530. 10.1016/j.nlm.2021.107530. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Han C. J., O’Tuathaigh Colm M., van Trigt Laurent, Quinn Jennifer J., Fanselow Michael S., Mongeau Raymond, Koch Christof, and Anderson David J.. “Trace but Not Delay Fear Conditioning Requires Attention and the Anterior Cingulate Cortex.” Proceedings of the National Academy of Sciences of the United States of America 100, no. 22 (October 28, 2003): 13087–92. 10.1073/pnas.2132313100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Cowansage Kiriana Kater, Shuman Tristan, Dillingham Blythe Christine, Chang Allene, Golshani Peyman, and Mayford Mark. “Direct Reactivation of a Coherent Neocortical Memory of Context.” Neuron 84, no. 2 (October 22, 2014): 432–41. 10.1016/j.neuron.2014.09.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Catlow Briony J., Song Shijie, Paredes Daniel A., Kirstein Cheryl L., and Sanchez-Ramos Juan. “Effects of Psilocybin on Hippocampal Neurogenesis and Extinction of Trace Fear Conditioning.” Experimental Brain Research 228, no. 4 (August 1, 2013): 481–91. 10.1007/s00221-013-3579-0. [DOI] [PubMed] [Google Scholar]
- 73.Williams Alex H., Tony Hyun Kim Forea Wang, Vyas Saurabh, Ryu Stephen I., Shenoy Krishna V., Schnitzer Mark, Kolda Tamara G., and Ganguli Surya. “Unsupervised Discovery of Demixed, Low-Dimensional Neural Dynamics across Multiple Timescales through Tensor Component Analysis.” Neuron 98, no. 6 (June 27, 2018) 1099–1115.e8. 10.1016/j.neuron.2018.05.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Pennington Zachary T., Dong Zhe, Feng Yu, Vetere Lauren M., Page-Harley Lucia, Shuman Tristan, and Cai Denise J.. “ezTrack: An Open-Source Video Analysis Pipeline for the Investigation of Animal Behavior.” Scientific Reports 9, no. 1 (December 27, 2019) : 19979. 10.1038/s41598-019-56408-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Vohryzek Jakub, Cabral Joana, Lord Louis-David, Fernandes Henrique M., Roseman Leor, Nutt David J., Carhart-Harris Robin L., Deco Gustavo, and Kringelbach Morten L.. “Brain Dynamics Predictive of Response to Psilocybin for Treatment-Resistant Depression.” Brain Communications 6, no. 2 (2024): fcae049. 10.1093/braincomms/fcae049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Ekins Tyler G, Brooks Isla, Kailasa Sameer, Rybicki-Kler Chloe, Jedrasiak-Cape Izabela, Donoho Ethan, Mashour George A., Rech Jason, and Ahmed Omar J. “Cellular Rules Underlying Psychedelic Control of Prefrontal Pyramidal Neurons.” Preprint. Neuroscience, October 23, 2023. 10.1101/2023.10.20.563334. [DOI] [Google Scholar]
- 77.Effinger D. P., Quadir S. G., Ramage M. C., Cone M. G., and Herman M. A.. “Sex-Specific Effects of Psychedelic Drug Exposure on Central Amygdala Reactivity and Behavioral Responding.” Translational Psychiatry 13, no. 1 (April 8, 2023): 119. 10.1038/s41398-023-02414-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Tomé Douglas Feitosa, Zhang Ying, Aida Tomomi, Mosto Olivia, Lu Yifeng, Chen Mandy, Sadeh Sadra, Roy Dheeraj S., and Clopath Claudia. “Dynamic and Selective Engrams Emerge with Memory Consolidation.” Nature Neuroscience, January 19, 2024, 1–12. 10.1038/s41593-023-01551-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Kwan Alex C., Olson David E., Preller Katrin H., and Roth Bryan L.. “The Neural Basis of Psychedelic Action.” Nature Neuroscience 25, no. 11 (November 2022): 1407–19. 10.1038/s41593-022-01177-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Park Youngmin, and Geffen Maria N.. “A Circuit Model of Auditory Cortex.” PLOS Computational Biology 16, no. 7 (July 27, 2020): e1008016. 10.1371/journal.pcbi.1008016. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.